No definition available.
Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers
CD2_NONHODGKIN_NAS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Typi alii et non specificati lymphomatis non-Hodgkin
Similar endpoints
↥List of similar endpoints to
Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers
based on the number of shared cases.
Similar with more cases:
- Other and unspecified types of non-Hodgkin lymphoma, hilmo
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1495 | 673 | 822 |
| Unadjusted period prevalence (%) | 0.30 | 0.23 | 0.36 |
| Median age at first event (years) | 64.96 | 64.13 | 65.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1362
- Matched controls
- 13620
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
323.0
451
*
JN4BD
NOMESCO Finland
Extensive body CT
28.5
323.0
488
261
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
329.6
323.0
872
73
L03AA02
ATC
filgrastim; parenteral
957.5
323.0
356
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3781.5
323.0
309
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
323.0
784
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
323.0
414
*
L03AA13
ATC
pegfilgrastim; parenteral
3266.8
296.8
276
*
A03FA01
ATC
metoclopramide; systemic, rectal
12.5
294.3
607
825
XW000
NOMESCO Finland
Bone marrow biopsy
34.5
280.7
371
146
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1511.6
263.3
248
*
H02AB02
ATC
dexamethasone; systemic
78.0
236.2
265
42
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
1202.7
215.6
205
*
M04AA01
ATC
allopurinol; systemic
7.6
200.2
562
1151
A04AA02
ATC
granisetron; systemic, transdermal
2235.5
193.4
183
*
A04AA01
ATC
ondansetron; systemic, rectal
31.7
189.7
255
98
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
471.3
170.7
167
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
154.1
167.7
175
13
JN4AD
NOMESCO Finland
Body CT examination
18.4
165.3
265
176
WW500
NOMESCO Finland
Blood transfusion
27.0
160.2
225
99
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
28.9
149.0
205
83
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
145.4
137
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
129.2
122
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
62.7
125.5
146
26
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
29.7
124.8
170
65
PJA10
NOMESCO Finland
Exploration of lymph nodes
95.1
124.7
137
16
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
660.6
124.3
121
*
JN6AD
NOMESCO Finland
CT of torso and neck
113.2
123.5
133
13
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.1
121.2
257
306
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1264.8
120.7
116
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
117.4
111
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1217.2
116.4
112
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
116.3
110
*
ZX120
NOMESCO Finland
Intravenous
7.9
116.3
289
447
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
114.2
108
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
594.9
112.6
110
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.2
110.6
335
680
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
109.9
104
*
WF002
NOMESCO Finland
Radical radiotherapy
241.3
109.4
111
5
D70.82
ICD-10 Finland
Drug-induced neutropenia
153.7
107.9
113
8
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
104.5
99
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
102.4
97
*
1XC02
NOMESCO Finland
NA
107.6
100.6
109
11
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
96.0
91
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
94.9
90
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
93.8
89
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
91.7
87
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
90.6
86
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
89.0
515
1948
C61
ICD-10 Finland
Malignant neoplasm of prostate
240.5
88.6
90
*
130
Kela drug reimbursment
Malignant tumour
+∞
88.5
84
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
85.3
81
*
R50.9
ICD-10 Finland
Fever, unspecified
4.5
84.0
342
938
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
83.2
83.3
93
12
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
82.1
78
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
835.8
81.3
79
*
N02AA05
ATC
oxycodone; systemic
4.6
81.2
323
862
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
81.0
77
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
78.9
75
*
H02AB06
ATC
prednisolone; systemic
2.9
76.9
801
4464
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
110.3
76.8
83
8
H02AB07
ATC
prednisone; oral
3.8
70.7
350
1128
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
189.7
69.8
72
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
68.7
292
819
Z51.5
ICD-10 Finland
Palliative care
11.1
68.6
135
134
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.8
68.4
153
192
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
354.0
68.2
68
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
690.8
67.6
66
*
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
66.2
63
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
66.2
63
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.4
65.5
165
249
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.4
61.2
83
30
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
60.9
58
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.8
60.7
127
141
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
60.6
718
4088
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
31.4
60.1
80
27
J01MA12
ATC
levofloxacin; systemic
3.2
60.0
375
1426
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
162.1
59.4
62
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
58.8
56
*
ZX112
NOMESCO Finland
Subcutaneous
22.3
58.6
86
41
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
57.7
55
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
56.6
54
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
54.1
56.4
67
13
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
55.6
53
*
J05AB11
ATC
valaciclovir; oral
3.6
53.8
273
877
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
52.4
50
*
JN4CD
NOMESCO Finland
Very extensive body CT
11.5
52.3
100
93
116
Kela drug reimbursment
Prostate cancer
+∞
51.4
49
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
49.2
47
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
135.0
49.1
52
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
172.7
48.2
50
*
115
Kela drug reimbursment
Breast cancer
+∞
47.1
45
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.7
46.4
97
107
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.4
46.4
128
217
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
48.5
46.4
56
12
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
45.0
43
*
A02BC02
ATC
pantoprazole; systemic
2.3
44.8
933
6614
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
44.7
86
81
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
25.9
44.4
62
25
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
97.3
43.0
47
5
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
42.9
390
1827
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
42.7
173
451
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
42.6
352
1557
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
41.9
40
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
41.9
40
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.9
41.8
78
69
A41.9
ICD-10 Finland
Sepsis, unspecified
6.7
40.0
106
170
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
39.3
138
311
B01AB05
ATC
enoxaparin; parenteral
2.3
39.0
452
2379
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
38.7
37
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
38.7
37
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
38.7
37
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
38.7
37
*
L01AA02
ATC
chlorambucil; oral
200.4
38.0
39
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
137.2
37.9
40
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
37.7
36
*
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
37.7
36
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
22.0
37.7
55
26
A07AA02
ATC
nystatin; oral
4.3
37.5
147
370
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.0
37.3
76
80
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
36.6
35
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
36.6
35
*
212
Kela drug reimbursment
Gout
7.8
35.5
84
114
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.2
35.5
115
237
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
35.3
159
453
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
126.6
34.8
37
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
40.3
34.5
43
11
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
33.5
32
*
A79
ICPC
Malignancy NOS
119.6
32.8
35
*
B72
ICPC
Hodgkin Lymphoma
+∞
32.4
31
*
HA1AA
NOMESCO Finland
X-ray mammography
6.8
32.0
83
129
B01AB10
ATC
tinzaparin; parenteral
4.9
31.3
106
229
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.7
31.3
93
173
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
30.4
137
390
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
30.3
29
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
30.3
29
*
TGC00
NOMESCO Finland
Bronchial lavation
6.7
29.8
78
123
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
29.3
28
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
29.3
28
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
29.3
28
*
ZX108
NOMESCO Finland
Inhalation
32.5
29.2
38
12
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.1
28.3
169
596
WZC30
NOMESCO Finland
Teaching
3.0
27.9
173
626
J05AB01
ATC
aciclovir; systemic
2.2
26.8
308
1570
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
142.7
26.7
28
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
26.4
409
2369
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
26.3
100
243
A04AA55
ATC
palonosetron, combinations; systemic
+∞
26.1
25
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
26.1
25
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
25.8
193
782
L02AE02
ATC
leuprorelin; implant, parenteral
24.6
25.7
36
15
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
25.1
24
*
L01BC06
ATC
capecitabine; oral
+∞
25.1
24
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
24.5
134
443
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.5
24.3
42
32
L01CB01
ATC
etoposide; systemic
+∞
24.0
23
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
24.0
23
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
24.0
23
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.2
24.0
34
15
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
23.0
22
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
23.0
22
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.8
22.7
58
89
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.3
22.6
61
101
Z3231
NOMESCO Finland
Registered nurse
2.0
22.5
373
2193
GEA00
NOMESCO Finland
Mediastinoscopy
45.8
22.4
27
6
127
Kela drug reimbursment
Transplant complication
11.1
22.2
42
39
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
52.9
22.1
26
5
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
21.9
21
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
21.9
21
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
21.9
21
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
21.9
21
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
21.9
21
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
21.9
21
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
21.9
21
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
116.8
21.6
23
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
21.6
415
2570
WW200
NOMESCO Finland
Immunization
5.2
21.1
66
131
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
20.9
20
*
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
+∞
20.9
20
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
20.9
20
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
37.8
20.8
26
7
Y77
ICPC
Malignant neoplasm prostate
213.0
20.6
21
*
L02BB03
ATC
bicalutamide; oral
213.0
20.6
21
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
22.7
20.4
29
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
20.3
236
1195
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
20.3
466
3053
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.8
20.2
58
104
4701
FHL
Neck lymph node removal
33.1
20.2
26
8
TAB00
NOMESCO Finland
Lumbar puncture
4.0
20.1
83
219
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
27.5
20.1
27
10
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
17.6
20.1
31
18
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.0
19.9
42
48
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.8
19.9
57
102
JMA10
NOMESCO Finland
Transabdominal total splenectomy
36.3
19.9
25
7
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
19.9
93
273
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
19.8
19
*
WW409
NOMESCO Finland
Other aferesis
202.7
19.6
20
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
202.7
19.6
20
*
TPX15
NOMESCO Finland
Removal of vascular injection port
46.7
19.2
23
5
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
18.8
18
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
18.8
18
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.8
18
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
18.8
18
*
V03AF03
ATC
calcium folinate; systemic
+∞
18.8
18
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
18.8
18
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
18.8
18
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.4
18.7
69
164
L02BA01
ATC
tamoxifen; oral
101.4
18.6
20
*
HAC20
NOMESCO Finland
Total mastectomy
101.4
18.6
20
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
38.9
18.6
23
6
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
18.6
330
1969
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
192.4
18.6
19
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
192.4
18.6
19
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
192.4
18.6
19
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
30.5
18.4
24
8
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.5
18.2
86
254
ZXE00
NOMESCO Finland
One hour or less
1.7
18.1
500
3437
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
17.8
151
652
EMA10
NOMESCO Finland
Biopsy of tonsil
67.5
17.7
20
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
17.7
17
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
17.7
17
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
17.7
17
*
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
17.7
17
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
17.7
17
*
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
+∞
17.7
17
*
3AA13
NOMESCO Finland
NA
+∞
17.7
17
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
17.7
17
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.7
17
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
17.7
17
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
17.7
17
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
17.7
423
2779
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
96.3
17.6
19
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.0
17.5
43
63
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
24.4
17.3
24
10
R4110
NOMESCO Finland
Physiotherapy
1.8
17.2
333
2042
D69.5
ICD-10 Finland
Secondary thrombocytopenia
31.9
17.1
22
7
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
50.6
17.0
20
*
WX110
NOMESCO Finland
Local anesthesy
1.6
17.0
793
6266
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
10.9
17.0
32
30
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.7
16.9
39
52
Z2221
NOMESCO Finland
Medical doctor
1.8
16.9
349
2182
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
6.8
16.9
42
63
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
16.7
16
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
16.7
16
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
16.7
16
*
1AA09
NOMESCO Finland
NA
+∞
16.7
16
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
16.7
16
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
16.7
16
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
16.7
16
*
390
Kela drug reimbursment
Ibrutinib
+∞
16.7
16
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
91.1
16.6
18
*
N05CF01
ATC
zopiclone; oral
1.7
16.6
459
3137
EBA10
NOMESCO Finland
Surgical removal of tooth
2.5
16.5
136
581
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
16.4
151
682
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
16.3
592
4357
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
40.6
16.3
20
5
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
16.0
279
1645
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
15.9
235
1301
J01MA14
ATC
moxifloxacin; systemic
2.4
15.9
141
625
J02AC01
ATC
fluconazole; systemic
1.7
15.9
438
2982
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
8.5
15.8
34
41
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
15.9
15.7
25
16
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.1
15.7
38
55
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
15.6
15
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
15.6
15
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
15.6
15
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
15.6
15
*
A04AD12
ATC
aprepitant; systemic
+∞
15.6
15
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
15.6
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.6
15
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
15.6
15
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
15.6
15
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
15.6
15
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
15.6
15
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
86.0
15.6
17
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
15.3
475
3335
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
45.5
15.1
18
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.9
15.0
62
165
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
15.2
14.9
24
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
14.9
116
478
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
32.1
14.8
19
6
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
57.3
14.8
17
*
ZZR00
NOMESCO Finland
Flap of skin
9.8
14.7
29
30
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
21.3
14.7
21
10
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.6
14
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
14.6
14
*
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
14.6
14
*
1512
Kela drug reimbursment
Ibrutinib
+∞
14.6
14
*
WW402
NOMESCO Finland
Leucoferesis
+∞
14.6
14
*
C50.99
ICD-10 Finland
Breast, unspecified
151.5
14.5
15
*
WX402
NOMESCO Finland
General anaesthesia
2.2
14.5
164
814
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
36.4
14.5
18
5
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
14.3
103
406
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.1
14.2
55
138
GD1AD
NOMESCO Finland
Thorax CT examination
3.4
14.2
70
216
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.1
14.1
34
49
9101
FHL
Bone biopsy
42.9
14.1
17
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
42.9
14.1
17
*
JAH01
NOMESCO Finland
Laparoscopy
3.8
13.7
57
153
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
13.6
13
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
13.6
13
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
13.6
13
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
13.6
13
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
13.6
13
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
13.6
13
*
L02BG04
ATC
letrozole; oral
11.0
13.5
25
23
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.3
13.5
67
208
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
141.3
13.5
14
*
A06AH03
ATC
naloxegol; oral
21.4
13.3
19
9
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.3
13.3
31
43
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
9.8
13.2
26
27
N02AX02
ATC
tramadol; systemic, rectal
1.6
13.2
538
4011
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
40.5
13.2
16
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.3
13.1
23
19
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
10.2
13.0
25
25
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
13.0
474
3438
A02BA02
ATC
ranitidine; systemic
1.7
13.0
288
1825
Z2446
NOMESCO Finland
Social worker
2.7
12.8
90
349
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
12.8
73
250
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
12.7
214
1239
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
70.5
12.6
14
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
12.5
12
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
12.5
12
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
12.5
12
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
12.5
12
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
12.5
12
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
12.5
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.5
12
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
12.5
12
*
C82
ICD-10 Finland
Follicular lymphoma
+∞
12.5
12
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
24.5
12.5
17
7
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
131.1
12.4
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.2
399
2807
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
16.0
12.1
19
12
B02.9
ICD-10 Finland
Zoster without complication
2.6
12.1
93
380
J01DB01
ATC
cefalexin; oral
1.6
12.0
996
8650
R4190
NOMESCO Finland
Nutritional therapy
4.8
12.0
39
83
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
11.9
122
581
ZXA05
NOMESCO Finland
Left side
1.6
11.9
342
2326
L57.0
ICD-10 Finland
Actinic keratosis
2.3
11.8
116
537
JAH00
NOMESCO Finland
Laparotomy
4.3
11.8
43
103
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
11.7
129
632
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
65.5
11.6
13
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
19.1
11.6
17
9
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.2
11.5
30
49
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.3
11.5
34
65
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
11.5
11
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
1BC01
NOMESCO Finland
NA
+∞
11.5
11
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
11.5
11
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
11.5
11
*
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
11.5
11
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
11.5
11
*
L02BG03
ATC
anastrozole; oral
120.9
11.4
12
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
120.9
11.4
12
*
JAH20
NOMESCO Finland
Staging laparotomy
120.9
11.4
12
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
120.9
11.4
12
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
120.9
11.4
12
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
15.2
11.3
18
12
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
11.3
242
1510
C03CA01
ATC
furosemide; systemic
1.5
11.2
454
3347
JFB30
NOMESCO Finland
Right hemicolectomy
12.8
11.1
19
15
6BA02
NOMESCO Finland
NA
25.2
11.1
15
6
UJF32
NOMESCO Finland
Coloscopy
1.6
11.1
314
2118
Z51.88
ICD-10 Finland
Other specified medical care
4.9
11.0
35
73
JFB00
NOMESCO Finland
Partial resection of small intestine
6.7
11.0
27
41
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.3
10.9
54
168
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.2
10.9
33
65
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
43.6
10.9
13
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
43.6
10.9
13
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
43.6
10.9
13
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
43.6
10.9
13
*
N03AX16
ATC
pregabalin; oral
1.6
10.8
288
1909
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
10.8
142
750
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.7
254
1629
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
21.6
10.7
15
7
5702
FHL
Local lymph node removal (eg armpit, groin)
60.4
10.6
12
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
60.4
10.6
12
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
60.4
10.6
12
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.3
10.6
31
59
E83.50
ICD-10 Finland
Hypercalcemia
7.0
10.6
25
36
A06AD11
ATC
lactulose; oral
1.8
10.5
209
1273
B03XA02
ATC
darbepoetin alfa; parenteral
5.1
10.5
32
64
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
10.5
65
235
ED1AA
NOMESCO Finland
Mandipular X-ray examination
14.3
10.5
17
12
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
110.8
10.4
11
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
110.8
10.4
11
*
ENA10
NOMESCO Finland
Biopsy of pharynx
110.8
10.4
11
*
WF099
NOMESCO Finland
Other radiotherapy
110.8
10.4
11
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
10.4
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
10.4
10
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
10.4
10
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
10.4
10
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
10.4
10
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
10.4
10
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
10.4
10
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
10.4
10
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
10.4
10
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
10.4
10
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
10.4
10
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
10.4
10
*
L01BB05
ATC
fludarabine; systemic
+∞
10.4
10
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
10.4
10
*
L01EL01
ATC
ibrutinib; oral
+∞
10.4
10
*
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
10.4
10
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
16.2
10.4
16
10
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
32.8
10.3
13
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
10.2
166
947
A02BC01
ATC
omeprazole; systemic
1.5
10.2
362
2580
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.7
10.1
33
71
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.5
10.1
29
54
R06AE07
ATC
cetirizine; oral
1.5
10.1
473
3580
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.9
10.1
32
67
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.0
10.1
31
63
ZX114
NOMESCO Finland
Intramuscular
6.1
10.0
26
43
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.6
10.0
71
281
GD6AD
NOMESCO Finland
CT of chest and neck
40.3
10.0
12
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
16.8
9.9
15
9
H02AB09
ATC
hydrocortisone; systemic
3.9
9.8
39
102
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
9.8
48
149
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
20.2
9.8
14
7
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.2
9.8
49
155
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.2
9.8
36
88
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
9.8
79
335
N02BE01
ATC
paracetamol; systemic, rectal
1.5
9.7
1066
9555
J94.8
ICD-10 Finland
Other specified pleural conditions
5.2
9.7
29
57
ZXD05
NOMESCO Finland
Urgent procedure
1.5
9.7
373
2702
B01AB04
ATC
dalteparin; parenteral
2.5
9.7
72
292
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.5
9.6
44
130
EMB10
NOMESCO Finland
Tonsillectomy
3.1
9.4
50
165
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.6
9.4
21
28
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
17.7
9.4
14
8
128
Kela drug reimbursment
Cancers of female genital organs
+∞
9.4
9
*
A04AA03
ATC
tropisetron; systemic
+∞
9.4
9
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
9.4
9
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
9.4
9
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
+∞
9.4
9
*
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
+∞
9.4
9
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
9.4
9
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
9.4
9
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
9.4
9
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
9.4
9
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
9.4
9
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
9.4
9
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
9.4
9
*
A05AA02
ATC
ursodeoxycholic acid; oral
5.3
9.2
27
52
J01MA01
ATC
ofloxacin; systemic
2.0
9.2
124
661
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4.1
9.1
34
85
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.1
9.0
21
30
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.6
9.0
22
34
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
24.2
8.9
12
5
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.8
8.7
35
93
1CX01
NOMESCO Finland
NA
50.3
8.7
10
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
50.3
8.7
10
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
8.7
135
759
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.9
8.7
51
181
A41.8
ICD-10 Finland
Other specified sepsis
4.4
8.6
30
70
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.3
8.6
42
131
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.8
8.6
54
197
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
11.6
8.6
15
13
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
8.6
286
1997
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
90.5
8.4
9
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
90.5
8.4
9
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
90.5
8.4
9
*
L04AA06
ATC
mycophenolic acid; systemic
4.9
8.4
26
54
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.9
8.4
26
54
L04AD01
ATC
ciclosporin; systemic
4.5
8.4
28
63
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
8.3
8
*
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
8.3
8
*
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
8.3
8
*
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
8.3
8
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
8.3
8
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
8.3
8
*
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
8.3
8
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
8.3
8
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
8.3
8
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.3
8
*
153
Kela drug reimbursment
Lenalidomid
+∞
8.3
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
8.3
8
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
8.3
8
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
8.3
8
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
8.3
8
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
8.3
8
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
8.3
8
*
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
8.3
8
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
8.3
8
*
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
8.3
8
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
8.3
8
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
8.3
8
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
8.3
8
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
8.3
8
*
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
8.3
8
*
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
8.3
8
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.2
8.3
42
135
TGD00
NOMESCO Finland
Needle biopsy of lung
14.6
8.2
13
9
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.1
8.1
43
143
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
33.5
8.1
10
*
CAA30
NOMESCO Finland
Biopsy of orbit
33.5
8.1
10
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
10.1
8.0
15
15
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
10.1
8.0
15
15
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.8
8.0
152
911
J35.1
ICD-10 Finland
Hypertrophy of tonsils
7.3
8.0
18
25
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.2
7.9
28
67
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.4
7.8
36
108
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.8
476
3750
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
10.9
7.8
14
13
WX882
NOMESCO Finland
High dependency care
3.1
7.7
41
137
CFA20
NOMESCO Finland
Biopsy of conjunctiva
15.1
7.7
12
8
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
45.2
7.7
9
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
7.7
60
251
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.2
7.6
27
65
DHB00
NOMESCO Finland
Excision of lesion of external nose
11.9
7.6
13
11
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
25.1
7.6
10
*
J02AC03
ATC
voriconazole; systemic
25.1
7.6
10
*
S77
ICPC
Malignant neoplasm of skin
25.1
7.6
10
*
N03AX14
ATC
levetiracetam; systemic
3.1
7.6
39
128
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
7.6
68
307
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
10.1
7.5
14
14
TK800
NOMESCO Finland
Hemodialysis
3.5
7.5
33
96
L04AA01
ATC
[U] ciclosporin; systemic
4.4
7.5
25
57
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
80.5
7.4
8
*
ZX130
NOMESCO Finland
Epidural
13.4
7.4
12
9
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.4
7.4
12
9
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
7.4
56
233
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.5
7.4
55
226
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
10.9
7.3
13
12
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
7.3
7
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
7.3
7
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
7.3
7
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
7.3
7
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
7.3
7
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
7.3
7
*
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
7.3
7
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
7.3
7
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
7.3
7
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
7.3
7
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
7.3
7
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
7.3
7
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
7.3
7
*
V03AB28
ATC
NA
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
7.3
7
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
L04AX04
ATC
lenalidomide; oral
+∞
7.3
7
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.3
7
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
7.3
7
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
7.2
114
647
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
7.2
385
2954
ZXA00
NOMESCO Finland
Right side
1.5
7.2
328
2439
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
30.2
7.1
9
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
30.2
7.1
9
*
J01FF01
ATC
clindamycin; systemic
1.5
7.1
307
2259
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
12.1
7.1
12
10
Z3226
NOMESCO Finland
Physiotherapist
1.6
7.1
207
1397
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
8.8
7.0
14
16
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
7.0
45
168
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
13.8
6.9
11
8
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
6.9
71
343
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.8
250
1778
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.0
6.8
25
63
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.4
6.8
13
14
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
40.2
6.8
8
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
40.2
6.8
8
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
40.2
6.8
8
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
6.7
212
1452
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
16.8
6.7
10
6
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
16.8
6.7
10
6
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
22.6
6.7
9
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
22.6
6.7
9
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
22.6
6.7
9
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.5
6.6
29
85
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
6.6
71
348
A07AA09
ATC
vancomycin; oral
4.1
6.6
24
60
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.6
126
759
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
6.6
73
362
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
8.7
6.6
13
15
D11.70
ICD-10 Finland
Gland sublingual
10.1
6.5
12
12
R18
ICD-10 Finland
Ascites
4.5
6.5
21
47
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
5.7
6.5
17
30
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
70.1
6.4
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
70.1
6.4
7
*
X76
ICPC
Malignant neoplasm breast female
70.1
6.4
7
*
B59
ICD-10 Finland
Pneumocystosis
70.1
6.4
7
*
5701
FHL
Local exploration of lymph nodes (includes biopsy)
70.1
6.4
7
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
70.1
6.4
7
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
70.1
6.4
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
70.1
6.4
7
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
70.1
6.4
7
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
6.4
68
333
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
14.4
6.4
10
7
KA1FN
NOMESCO Finland
Isotope renography
8.2
6.3
13
16
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
11.1
6.3
11
10
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
11.1
6.3
11
10
N74
ICPC
Malignant neoplasm nervous system
+∞
6.3
6
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
6.3
6
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
6.3
6
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
6.3
6
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
6.3
6
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
6.3
6
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
6.3
6
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
372
Kela drug reimbursment
Idelalisib
+∞
6.3
6
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
6.3
6
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
6.3
6
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
6.3
6
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
329
Kela drug reimbursment
Lenalidomide
+∞
6.3
6
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
6.3
6
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
+∞
6.3
6
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
26.8
6.2
8
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
26.8
6.2
8
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
26.8
6.2
8
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
26.8
6.2
8
*
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
6.3
6.2
15
24
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
6.3
6.2
15
24
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.9
6.1
23
60
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
4.4
6.0
20
46
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.4
6.0
20
46
J18
ICD-10 Finland
Pneumonia, organism unspecified
6.7
6.0
14
21
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
6.7
6.0
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011412) CD3 cells [#/volume] in Blood
192
53
41.42
313.45
2.8
2.2
e9/l
1.2
1.0
0.50
140
29
(46235355) HIV 1 and 2 tests - Meaningful Use set
626
1239
7.97
307.65
1.6
1.6
—
—
—
0
0
(4035726)
514
327
23.43
307.65
1.8
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
527
531
14.78
307.65
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
574
896
9.78
307.65
1.5
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
306
21
182.96
307.65
1.4
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
265
154
20.70
307.65
1.8
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
593
1009
9.08
307.65
1.5
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
853
1163
15.75
307.65
8.2
3.2
u/l
270.0
237.1
5.11
830
1076
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
231
11
248.20
307.65
1.4
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
269
79
41.30
307.65
1.5
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
437
707
8.32
274.55
4.3
2.1
g/l
8.9
10.8
12.63
419
643
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
156
37
46.96
263.81
2.4
2.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
159
41
43.28
263.49
2.3
2.5
%
15.4
13.5
0.31
62
17
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
194
113
19.58
240.76
3.7
2.6
u/ml
11707.9
414.5
0.70
29
13
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
198
149
15.16
214.63
6.7
5.8
iu/ml
6920.5
435.5
0.47
33
20
(3028026) IgM [Mass/volume] in Serum or Plasma
331
571
7.16
191.89
3.4
1.4
g/l
1.7
1.2
1.73
316
517
(42870588) Differential panel, method unspecified - Blood
888
3605
4.60
186.21
10.8
5.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1041
4862
4.76
177.83
11.1
5.6
%
0.7
0.7
0.20
1004
4464
(40765096) Chromosome analysis panel by Banding
102
21
52.05
177.12
1.2
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1052
5003
4.72
173.97
11.3
5.6
%
2.6
3.0
4.78
1019
4585
(3019069) Monocytes/100 leukocytes in Blood
1053
5023
4.71
173.10
11.9
5.8
%
9.4
8.8
5.64
1017
4623
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
113
39
31.26
171.45
3.1
1.7
e6/l
629.2
531.6
0.40
98
33
(3002030) Lymphocytes/100 leukocytes in Blood
1053
5118
4.58
166.17
11.7
5.7
%
27.4
26.9
0.49
1015
4686
(3001604) Monocytes [#/volume] in Blood
1083
5384
4.67
165.34
10.4
5.3
e9/l
0.6
0.6
0.08
982
4599
(3006315) Basophils [#/volume] in Blood
1086
5415
4.68
164.98
10.4
5.3
e9/l
0.0
0.0
4.35
984
4634
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
109
38
30.86
164.77
3.2
1.8
e9/l
0.2
0.2
0.11
98
33
(3026493) Urate [Moles/volume] in Serum or Plasma
781
3101
4.18
163.52
6.0
2.5
umol/l
3577.3
6733.1
1.18
743
2640
(21494814) CD8 cells/100 lymphocytes in Specimen
95
21
48.24
162.32
2.2
2.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1098
5604
4.61
159.26
11.3
5.5
e9/l
0.2
0.2
11.29
1001
4863
(3018010) Neutrophils/100 leukocytes in Blood
1035
5070
4.38
158.91
10.7
5.5
%
56.9
58.1
1.85
1001
4668
(3019198) Lymphocytes [#/volume] in Blood
1085
5510
4.53
157.96
10.6
5.4
e9/l
2.0
1.8
0.83
997
4789
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
107
41
28.03
156.62
3.5
1.5
e6/l
441.6
997.8
2.72
43
18
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
87
15
61.52
156.12
2.2
3.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1115
5976
4.41
145.33
23.8
6.3
e9/l
3.7
4.4
16.40
1029
5131
(3017181) Myelocytes/100 leukocytes in Blood
353
832
5.25
144.67
7.2
4.0
%
1.0
0.7
0.80
211
192
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
101
45
24.00
139.65
3.6
2.3
%
35.9
43.3
1.11
40
19
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1049
5483
4.06
139.46
14.8
3.9
umol/l
10.9
12.1
2.03
1027
5114
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
159
166
10.60
138.65
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
141
126
12.25
136.63
5.1
3.3
%
2.1
1.5
0.54
121
86
(3012095) Magnesium [Moles/volume] in Serum or Plasma
491
1603
4.07
131.01
6.8
2.5
mmol/l
0.8
0.8
2.23
469
1461
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
140
144
10.62
123.14
1.4
1.4
u/ml
106.6
115.5
0.36
36
20
(3027945) Reticulocytes/100 erythrocytes in Blood
445
1414
4.06
122.42
4.3
2.1
%
1.8
1.8
0.52
407
1221
(3021440) Promyelocytes/100 leukocytes in Blood
320
797
4.84
121.36
7.4
4.1
%
0.2
0.1
2.23
194
174
(3002179) Metamyelocytes/100 leukocytes in Blood
308
763
4.82
117.34
6.9
3.8
%
0.6
0.6
0.04
148
143
(3024561) Albumin [Mass/volume] in Serum or Plasma
926
4805
3.44
116.60
8.5
3.7
g/l
34.0
35.4
10.69
887
4401
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
170
260
7.25
108.15
1.7
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
356
1060
4.10
105.85
4.2
2.2
e9/l
70.6
69.2
0.27
303
829
(3023368) Bacteria identified in Blood by Culture
686
3139
3.19
103.56
8.8
4.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
150
210
7.83
103.18
2.8
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
726
3444
3.15
102.73
2.7
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
152
224
7.44
99.86
2.6
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
333
988
4.05
99.00
3.2
1.6
g/l
63.7
66.8
8.33
314
886
(3025159) Blasts/100 leukocytes in Blood
284
761
4.37
96.82
6.9
4.2
%
0.0
0.7
0.58
155
153
(3004588) Protein electrophoresis panel - Serum or Plasma
302
849
4.20
96.55
2.8
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
249
607
4.72
95.75
2.7
1.4
ug/l
10.7
3.3
0.81
197
463
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
124
154
8.69
94.17
2.7
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
968
5706
2.98
87.64
11.5
5.3
mmol/l
1.2
1.2
3.67
825
4815
(3002256) Pathology report gross observation
279
803
4.04
85.74
1.5
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
401
1470
3.36
85.52
7.4
4.9
mmol/l
1.1
1.0
1.11
384
1342
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
47
10
48.49
80.35
1.4
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
887
5183
2.75
78.23
10.1
4.9
mmol/l
1.2
1.2
3.77
850
4581
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
173
367
5.20
77.99
2.5
3.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
60
32
19.49
76.47
4.7
2.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
690
3628
2.67
74.13
6.7
2.1
mmol/l
2.4
2.4
0.04
633
2978
(3044640) Blood type and Crossmatch panel - Blood
631
3178
2.71
73.89
4.3
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
536
2512
2.77
72.01
17.1
4.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
130
235
5.96
69.65
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
97
130
7.91
68.89
2.0
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
104
151
7.33
68.86
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
84
96
9.21
67.86
6.7
3.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
635
3316
2.59
67.69
8.3
3.2
ph
7.4
7.4
0.02
153
566
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
117
196
6.39
67.68
1.9
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
73
69
11.07
67.62
1.9
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
105
159
7.03
66.89
2.0
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
108
175
6.57
64.50
1.3
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
18
25.16
62.31
4.4
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
435
1967
2.71
61.16
2.9
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
472
2239
2.62
60.09
10.0
4.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
802
4851
2.41
59.89
6.7
3.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
234
760
3.46
58.95
2.6
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
416
1872
2.69
58.75
2.5
1.3
g/l
2.0
2.7
11.20
329
1064
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
76
92
8.65
58.63
2.9
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
87
124
7.39
58.47
1.9
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
98
161
6.44
57.68
1.2
1.2
u/ml
315.1
240.5
0.87
60
95
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
79
103
8.04
57.34
2.9
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
789
4801
2.36
57.26
18.2
8.6
e9/l
0.0
0.0
0.79
674
3905
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
78
102
8.01
56.46
2.2
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
515
2643
2.45
54.55
6.1
3.5
%
86.8
85.3
0.65
503
2567
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1165
8563
2.63
53.18
18.9
5.4
u/l
83.2
76.9
3.59
1144
7876
(3017354) Segmented neutrophils/100 leukocytes in Blood
72
93
8.08
52.64
5.8
3.2
%
50.6
53.5
0.31
50
56
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
144
361
4.31
52.41
3.6
1.4
mg/l
38.1
50.1
0.33
119
287
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
64
72
9.24
52.23
2.5
2.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
140
345
4.37
52.10
3.6
1.4
ratio
7.0
1.2
1.28
15
29
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
438
2129
2.50
51.83
5.0
2.2
mmol/l
2.5
2.4
6.70
419
1811
(44790049)
76
107
7.43
51.59
2.1
1.5
—
—
—
0
0
(44806118)
76
107
7.43
51.59
2.1
1.5
—
—
—
0
0
(44790048)
76
107
7.43
51.59
2.1
1.5
—
—
—
0
0
(44790047)
76
107
7.43
51.59
2.1
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
113
237
5.08
51.21
1.6
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
778
4865
2.25
50.87
11.3
10.7
inr
1.2
1.4
4.76
208
1345
(3034860) Kappa light chains.free [Mass/volume] in Serum
142
361
4.24
50.70
3.6
1.4
mg/l
68.8
44.2
1.77
117
287
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
325
1380
2.73
50.67
2.6
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
63
73
8.97
50.24
1.3
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
61
69
9.17
49.55
1.3
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
44
30
15.08
49.50
2.4
2.6
u/ml
6848.1
6647.8
—
9
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
107
225
5.05
48.31
2.2
1.9
u/ml
66.9
66.7
0.00
87
176
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
78
124
6.58
47.32
2.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
318
1380
2.66
47.19
2.8
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
473
2476
2.33
46.62
4.2
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
82
140
6.14
46.37
2.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
115
267
4.58
46.07
3.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
272
1111
2.77
45.33
5.3
2.2
umol/l
7.9
8.3
0.11
250
964
(3037692) Legionella sp identified in Specimen by Organism specific culture
42
31
13.91
45.20
1.3
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
158
471
3.63
44.96
2.9
1.7
ug/l
1.7
1.8
0.08
141
405
(21494434) Karyotype in Bone marrow
67
98
7.11
43.91
1.2
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
544
3100
2.19
42.96
4.1
2.9
e6/l
0.3
0.4
1.89
424
2356
(36304419) Bacteria [Presence] in Urine
532
3006
2.20
42.92
4.1
2.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
168
542
3.37
42.23
2.2
1.6
g/l
1.6
1.5
0.19
136
460
(3042936) Bacteria identified in Isolate by Culture
333
1556
2.47
41.85
2.3
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
578
3401
2.14
41.79
4.3
3.0
e6/l
34.4
81.0
1.48
457
2620
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
142
415
3.68
41.55
3.0
1.4
g/l
1.7
0.4
3.68
123
356
(3013707) Erythrocyte sedimentation rate by Westergren method
1124
8538
2.28
40.85
6.9
4.1
mm/h
17.2
12.6
12.96
1072
7824
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
88
182
5.08
40.44
5.2
3.0
%
56.6
58.8
0.63
88
182
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
495
3.38
39.53
2.8
1.4
g/l
3.6
3.9
0.83
115
359
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
495
3.38
39.53
2.8
1.4
g/l
7.1
7.5
1.52
120
370
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
495
3.38
39.53
2.8
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
462
3.45
39.12
2.9
1.4
g/l
3.3
3.1
1.46
117
364
(3018095) Leukocytes [#/volume] in Urine
636
3995
2.03
37.55
5.1
3.5
e6/l
67.5
110.7
1.36
475
2822
(3030905) Polymorphonuclear cells [#/volume] in Blood
84
178
4.94
37.51
4.3
2.8
e9/l
3.4
4.4
3.46
84
178
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
57
84
7.02
37.07
3.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
57
84
7.02
37.07
3.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
57
84
7.02
37.07
3.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
73
138
5.51
37.07
2.6
2.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
314
1508
2.37
36.66
2.6
2.6
%
22.9
22.7
0.06
287
1262
(3018677) aPTT in Platelet poor plasma by Coagulation assay
352
1792
2.26
35.76
3.0
1.9
s
30.0
30.0
0.03
343
1727
(3022948) Iron [Moles/volume] in Serum or Plasma
348
1771
2.26
35.34
2.6
2.4
umol/l
12.7
12.9
0.17
327
1612
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
124
371
3.55
34.92
3.2
1.4
g/l
0.0
0.0
0.43
118
339
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
209
854
2.68
34.26
2.3
2.0
g/l
0.2
0.2
0.02
191
767
(3004789) Transferrin [Mass/volume] in Serum or Plasma
324
1622
2.27
34.10
2.6
2.4
g/l
2.2
2.3
3.29
303
1492
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
18
16.41
34.10
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
404
2214
2.13
33.88
3.5
2.6
mosm/kgh2o
543.0
551.8
0.38
353
1856
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
464
3.23
33.50
2.9
1.4
g/l
9.9
10.5
0.70
124
391
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
114
333
3.62
33.26
1.9
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
100
270
3.90
32.70
1.6
2.0
mg/l
12.3
12.2
0.03
91
247
(3008536) Aspergillus sp Ab [Presence] in Serum
26
14
18.88
32.66
4.2
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
356
3.48
32.08
3.0
3.4
u/ml
0.3
0.4
0.77
66
213
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
44
58
7.79
31.54
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
45
8.87
31.12
3.8
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
45
8.87
31.12
3.8
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
45
8.87
31.12
3.8
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
45
8.87
31.12
3.8
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
59
109
5.59
30.69
1.2
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
918
6834
1.89
30.19
7.9
4.3
mmol/l
6.7
6.9
1.16
890
6371
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
33
32
10.52
29.86
4.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
33
32
10.52
29.86
4.2
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
33
32
10.52
29.86
4.2
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
413
2386
2.01
29.42
3.3
2.4
e6/l
4.3
5.4
1.20
371
2082
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
121
400
3.20
29.01
3.2
1.4
g/l
35.6
37.5
2.33
110
336
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
111
352
3.33
28.48
3.3
1.4
g/l
0.0
0.0
0.00
105
321
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
110
347
3.34
28.46
3.3
1.4
g/l
0.0
0.0
0.00
105
320
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
327
1754
2.11
28.41
3.8
2.7
e6/l
2.1
2.5
0.41
183
959
(3020779) Urea [Moles/volume] in Serum or Plasma
219
997
2.40
28.34
8.0
6.7
mmol/l
10.5
10.8
0.17
209
940
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
5
65.31
28.01
2.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
30
28
10.91
27.83
1.5
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
67
152
4.57
27.54
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
65
144
4.67
27.51
7.9
7.4
mg/l
12.0
12.2
0.12
58
133
(40768806) Pleura Pathology biopsy report
49
88
5.72
26.26
1.7
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
50
7.56
25.95
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
50
7.56
25.95
2.1
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
52
100
5.35
25.90
1.8
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
96
297
3.39
25.60
1.9
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
474
2982
1.86
25.56
2.4
2.2
mg/l
3.5
3.0
3.70
412
2496
(3021447) Carbon dioxide [Partial pressure] in Venous blood
235
1150
2.24
25.56
4.1
3.1
kpa
5.7
5.8
0.86
226
1104
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
338
1904
2.00
25.38
3.5
2.6
e6/l
1.3
1.4
0.14
195
1105
(3002032) Base excess in Venous blood by calculation
233
1144
2.23
25.11
4.1
3.1
mmol/l
1.8
2.1
0.32
189
909
(3031040) Bacteria [#/volume] in Urine by Automated count
965
7515
1.80
25.10
6.0
4.5
e6/l
255.6
2149.1
1.74
22
117
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
59
6.76
24.74
2.1
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
192
876
2.37
24.57
8.6
3.0
mmol/l
1.2
1.2
0.39
186
736
(3000991) Gas panel - Venous blood
203
951
2.31
24.44
7.1
6.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
122
448
2.88
24.30
1.6
1.8
u/l
41.8
39.1
0.62
101
383
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
166
713
2.49
24.25
1.9
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
39
61
6.54
23.98
1.5
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
428
2696
1.82
22.48
1.6
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
136
552
2.61
22.31
4.1
3.4
mmol/l
24.2
24.4
0.24
123
479
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
38
8.04
22.19
1.4
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
49
103
4.88
22.08
3.3
2.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
42
77
5.58
22.03
2.2
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
244
1290
2.07
21.54
2.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
35
55
6.49
21.42
2.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
35
55
6.49
21.42
2.2
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
75
223
3.49
21.27
1.6
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
51
115
4.56
21.13
1.3
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
33
50
6.73
20.90
2.4
2.5
u/ml
4622.1
1141.2
2.22
33
50
(3023199) Leukocytes [#/volume] in Pleural fluid
52
121
4.42
20.72
1.4
1.6
e6/l
1843.3
1733.2
0.08
37
85
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
190
926
2.20
20.66
2.7
2.1
u/l
36.1
38.9
0.19
166
770
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
83
273
3.16
20.04
3.1
2.2
%
91.6
88.3
0.60
83
260
(3037467) Urinalysis macro (dipstick) panel - Urine
977
7916
1.68
19.23
5.4
4.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
78
255
3.17
19.02
1.7
1.2
e6/l
15.3
38.7
0.50
64
210
(3014111) Lactate [Moles/volume] in Serum or Plasma
195
994
2.11
18.85
6.3
5.7
mmol/l
1.7
1.4
1.21
190
953
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
77
255
3.13
18.38
1.8
1.3
e6/l
625.1
631.3
0.00
65
217
(40758292) HTLV I+II Ab panel - Serum
24
8
30.46
18.36
1.5
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
366
2328
1.76
18.01
2.0
1.8
mg/l
1.8
1.3
1.36
301
1787
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
76
253
3.11
17.99
1.2
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
23
7
33.34
17.98
1.7
3.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
249
1407
1.92
17.98
8.8
5.5
mmol/l
104.2
104.2
0.01
241
1367
(3016018) Differential panel - Cerebral spinal fluid
44
103
4.37
17.42
1.4
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
56
157
3.67
17.36
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
117
498
2.46
17.34
1.4
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
232
1298
1.93
17.21
2.0
1.8
—
—
—
0
0
(4062490)
42
96
4.47
17.14
1.7
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
508
3569
1.64
17.09
3.8
3.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
45
109
4.23
17.06
1.5
1.6
e6/l
33871.7
90377.0
0.44
24
61
(3024139) IgG subclass 3 [Mass/volume] in Serum
42
97
4.43
16.92
1.7
1.4
g/l
0.3
0.4
0.35
29
69
(3027135) IgG subclass 1 [Mass/volume] in Serum
42
97
4.43
16.92
1.7
1.4
g/l
6.0
6.9
0.53
30
70
(3028192) IgG subclass 2 [Mass/volume] in Serum
42
97
4.43
16.92
1.7
1.4
g/l
2.5
2.9
0.61
31
70
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
153
744
2.18
16.63
2.0
1.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
22
8
27.88
16.52
1.1
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
610
4514
1.59
16.41
3.5
2.7
ug/l
383.3
135.1
7.24
568
4096
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
475
3312
1.64
16.31
5.8
2.6
u/l
33.9
35.2
0.16
452
3131
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
546
3942
1.61
16.25
4.1
3.1
ng/l
2179.7
1593.7
1.00
500
3376
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
74
260
2.94
15.96
1.6
1.2
mmol/l
3.8
3.9
0.22
69
240
(3025941) Bacteria identified in Stool by Culture
122
550
2.33
15.90
1.5
1.2
—
—
—
0
0
(3036489) Thrombin time
90
353
2.65
15.79
2.6
1.9
s
21.6
21.2
0.30
84
314
(3024980) IgG subclass 4 [Mass/volume] in Serum
53
154
3.53
15.60
1.7
1.8
g/l
0.6
1.0
1.74
40
119
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
42
105
4.09
15.29
1.3
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
30
57
5.35
15.17
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
207
1165
1.90
14.98
6.4
3.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
72
259
2.87
14.90
3.2
2.8
mg/l
1.7
1.6
0.31
67
227
(3017732) Neutrophils [#/volume] in Blood
145
724
2.11
14.70
2.9
3.1
e9/l
3.8
4.2
1.10
102
518
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
490
3517
1.58
14.60
3.4
2.3
u/l
50.5
59.1
6.35
462
3207
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
32
67
4.86
14.52
1.2
1.0
mg/l
476.7
258.4
1.33
26
62
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
209
1195
1.87
14.38
5.5
3.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
62
211
3.02
14.17
1.6
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
175
954
1.95
13.90
3.2
2.6
kpa
4.6
4.5
0.33
168
911
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
32
70
4.65
13.80
1.3
1.1
mg/l
75.1
35.6
2.11
25
61
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
17
19
9.04
13.79
1.6
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
102
3.90
13.38
1.2
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
23
7.91
13.17
1.2
1.1
ug/l
10.5
1.3
—
7
9
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
50
5.27
12.98
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
68
257
2.72
12.86
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
68
257
2.72
12.86
1.6
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
62
4.75
12.85
1.6
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
601
4614
1.51
12.76
2.4
2.2
nmol/l
76.3
78.6
1.23
552
4005
(3009343) pH of Capillary blood
145
763
2.00
12.73
4.4
3.5
ph
7.4
7.4
0.29
21
91
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
54
181
3.06
12.69
1.3
1.3
miu/ml
84.0
222.1
—
9
68
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
67
4.55
12.63
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
80
4.20
12.54
2.5
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
146
776
1.98
12.45
4.5
3.5
kpa
5.0
5.2
1.42
141
706
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
50
165
3.10
12.07
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
138
732
1.98
11.84
4.3
3.4
mmol/l
2.3
1.8
0.87
107
530
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
76
317
2.47
11.79
1.4
1.6
iu/ml
0.1
0.1
0.00
22
70
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
619
4837
1.48
11.77
4.6
3.9
ng/l
63.8
61.2
0.03
511
3559
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
41
123
3.40
11.55
2.9
3.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
37
5.74
11.49
1.5
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
104
503
2.15
11.44
3.2
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
86
3.90
11.40
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
220
1365
1.72
11.38
8.6
6.1
mmol/l
1.6
1.3
0.48
163
1042
(3037522) Nuclear Ab [Titer] in Serum
226
1420
1.70
11.15
1.4
1.3
titre
597.9
544.1
0.15
56
328
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
219
1366
1.71
11.10
8.5
6.2
kpa
5.0
5.1
0.57
200
1302
(3027801) Oxygen [Partial pressure] in Arterial blood
219
1366
1.71
11.10
8.5
6.1
kpa
12.2
11.5
1.12
202
1298
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
11
10.99
11.07
1.8
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
36
102
3.59
11.06
1.6
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
63
250
2.59
10.86
1.4
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
18
29
6.27
10.74
1.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
5
28.24
10.73
1.9
3.6
mg/l
2.1
1.1
—
9
5
(3036048) Francisella tularensis Ab [Titer] in Serum
17
26
6.60
10.64
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
237
1528
1.65
10.57
1.3
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
12
10.07
10.45
2.0
1.6
%
4.4
5.3
—
7
6
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
348
2466
1.54
10.40
4.5
4.0
ng/l
757.7
456.3
0.25
300
2063
(4027681)
24
54
4.50
10.03
1.5
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
46
4.84
10.02
1.3
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
17
28
6.13
9.93
1.4
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
71
312
2.34
9.86
1.8
1.6
g/l
0.2
0.2
0.13
63
299
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
51
4.56
9.79
3.1
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
59
239
2.53
9.77
3.9
3.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
95
473
2.08
9.72
2.0
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
19
7.43
9.71
2.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
18
33
5.51
9.46
1.8
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
100
513
2.02
9.44
1.1
1.6
—
33.2
—
0
15
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
9
0
+∞
9.38
1.1
0.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
9
0
+∞
9.38
1.1
0.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
808
6812
1.41
9.37
4.0
3.0
u/l
59.1
49.3
1.87
761
6207
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
23
6.58
9.36
1.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
30
5.72
9.28
2.5
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
48
181
2.71
9.18
1.4
1.3
u/l
11.2
8.6
0.69
38
146
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
59
4.12
8.99
2.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
87
432
2.08
8.98
1.2
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
13
7
18.72
8.93
1.5
1.0
u/ml
30.7
14.6
—
13
7
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
21
47
4.52
8.85
3.6
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
106
570
1.93
8.75
4.8
3.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
89
3.42
8.65
1.2
1.2
u/l
57.3
49.7
0.25
24
61
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
61
3.98
8.62
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
13
19
6.89
8.45
2.1
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
54
226
2.44
8.39
2.5
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
44
167
2.68
8.34
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
43
162
2.70
8.27
2.3
2.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
59
3.94
8.16
2.4
1.2
—
—
—
0
0
(3010421) pH of Blood
65
300
2.22
8.09
3.9
4.2
ph
7.4
7.4
0.06
56
245
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
20
6.55
8.07
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
166
1045
1.66
8.06
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
65
3.74
7.91
1.3
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
107
597
1.85
7.91
8.3
7.8
mmol/l
24.0
24.4
0.57
98
539
(3012501) Base excess in Blood by calculation
56
247
2.32
7.77
4.0
4.4
mmol/l
2.9
2.8
0.11
49
173
(3024869) Neuronal Ab [Presence] in Serum
13
21
6.24
7.72
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
90
481
1.93
7.59
5.1
3.7
mmol/l
25.4
24.8
0.98
84
440
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
25
5.64
7.55
1.8
1.9
iu/ml
—
1424630.0
—
0
5
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
65
310
2.15
7.48
1.1
1.3
—
25.6
—
0
5
(3035350) Ketones [Presence] in Urine by Test strip
668
5589
1.35
7.45
4.5
3.7
estimate
0.0
0.0
0.00
156
974
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
22
5.95
7.38
1.2
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
186
1233
1.58
7.32
9.6
6.4
%
95.0
94.9
0.01
174
1182
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
46
4.17
7.28
2.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
46
4.17
7.28
2.6
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
147
923
1.66
7.21
3.4
3.6
ng/l
79.8
90.3
0.76
119
791
(3021601) Nitrite [Presence] in Urine by Test strip
667
5602
1.34
7.16
6.2
5.0
estimate
0.0
0.0
0.00
158
976
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
16
6.92
7.15
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
341
2577
1.42
7.03
1.9
1.8
nmol/l
1172.3
1161.0
0.07
268
1929
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
97
545
1.83
7.03
2.7
3.0
pmol/l
4.0
4.5
4.51
85
465
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
11
8
13.84
6.89
1.2
1.1
%
102.5
110.0
—
11
8
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
8
13.84
6.89
1.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1219
11272
1.44
6.85
38.0
13.6
mg/l
25.6
24.6
0.49
1129
8826
(3009261) Glucose [Presence] in Urine by Test strip
671
5673
1.33
6.76
4.7
3.7
estimate
0.0
0.0
0.80
157
945
(21494890) Protein electrophoresis panel - 24 hour Urine
29
99
2.97
6.71
2.0
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
389
3031
1.38
6.67
1.7
1.6
nmol/l
19.7
20.6
0.59
334
2521
(4281824)
20
54
3.74
6.65
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
132
826
1.66
6.57
7.7
4.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
101
588
1.77
6.53
4.8
3.3
%
50.2
48.2
0.35
101
577
(40768441) Liver Pathology biopsy report
18
46
3.95
6.44
1.2
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
160
2.48
6.39
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
33
125
2.68
6.34
3.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
56
3.61
6.32
1.4
1.0
u/l
1.4
1.1
0.35
11
31
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
61
3.48
6.30
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
12
22
5.49
6.29
1.7
1.3
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
33
126
2.66
6.25
3.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
62
313
2.02
6.20
3.0
3.2
mmol/l
24.8
25.0
0.15
57
272
(3002173) Hemoglobin [Mass/volume] in Arterial blood
167
1122
1.55
6.19
10.3
6.5
g/l
110.6
122.3
9.81
156
1079
(3005988) Vibrio sp identified in Specimen by Organism specific culture
33
127
2.63
6.16
3.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
56
274
2.08
6.09
1.1
1.1
titre
98.0
91.4
—
5
21
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
106
2.77
5.97
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
30
112
2.71
5.94
1.7
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
49
3.71
5.93
6.2
4.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
119
2.64
5.82
1.9
1.9
u/l
656.7
1283.9
0.34
13
49
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
33
131
2.55
5.80
3.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
9
11.18
5.79
4.7
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
24
5.03
5.75
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
33
132
2.53
5.72
3.2
1.2
—
—
—
0
0
(3013512) EKG study
445
3613
1.33
5.70
5.1
4.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
142
941
1.56
5.60
3.0
1.7
nmol/l
364.7
364.7
0.00
135
843
(3034770) Mitochondria Ab [Titer] in Serum
56
285
2.00
5.51
1.1
1.1
—
1714.0
—
0
10
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
17
47
3.65
5.49
1.4
1.1
ng/l
3152.6
53.1
—
10
11
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
60
314
1.95
5.46
1.5
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
70
386
1.85
5.44
2.2
2.5
g/l
0.7
0.3
0.82
38
129
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
5
16.08
5.41
1.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
32
132
2.46
5.23
3.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
59
3.25
5.18
1.2
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
32
133
2.44
5.15
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
133
887
1.55
5.11
5.2
3.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
31
4.22
5.09
1.6
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
27
4.47
5.04
2.6
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
316
1.90
5.04
1.5
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
86
517
1.70
5.02
9.3
4.3
%
1.6
1.7
0.29
76
488
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
192
1386
1.44
5.02
1.3
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
472
3923
1.30
4.99
2.4
2.2
u/l
136.0
243.3
3.32
443
3670
(42529406) Shigella sp [Presence] in Stool by Culture
59
319
1.88
4.90
1.5
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
163
2.24
4.80
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
45
223
2.05
4.79
3.0
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
347
2779
1.32
4.78
4.3
3.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
103
2.55
4.64
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
86
2.70
4.59
1.3
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
86
2.70
4.59
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
38
180
2.14
4.56
3.1
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
993
9108
1.27
4.45
42.2
16.2
%
14.5
13.7
38.19
982
8845
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
65
2.95
4.45
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
35
3.74
4.37
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
35
3.74
4.37
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
13
6.96
4.16
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
68
406
1.71
4.12
2.9
1.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
10
8.04
4.06
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
86
2.58
4.06
1.1
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
37
3.54
4.05
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
42
3.36
4.04
1.1
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1096
11625
0.79
3.99
4.8
5.4
mmol/l
2.6
2.6
0.75
981
10589
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
128
895
1.47
3.97
3.3
2.3
ml/min/173m2
59.0
63.9
0.59
58
362
(3029937) Albumin [Presence] in Urine by Test strip
371
3074
1.28
3.88
5.1
4.0
estimate
0.0
0.0
0.36
152
944
(3023183) Ammonium ion [Moles/volume] in Plasma
43
228
1.91
3.85
3.2
2.9
umol/l
32.4
35.4
0.39
37
199
(3020682) Albumin/Creatinine [Ratio] in Urine
346
4152
0.78
3.84
4.0
4.0
mg/mmol
11.3
8.2
0.64
232
2648
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
194
1.98
3.79
1.5
1.2
iu/l
25.8
25.7
0.01
33
165
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1021
10897
0.80
3.77
6.0
6.4
mmol/mol
40.5
40.7
0.35
919
9998
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
92
608
1.55
3.74
14.1
9.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
115
798
1.48
3.72
10.5
6.2
mmol/l
25.4
24.5
1.29
104
742
(3052851) Hemolysis interference index of Serum or Plasma
57
334
1.73
3.72
4.8
3.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
599
5260
1.23
3.72
2.2
2.0
pmol/l
92.2
93.6
0.30
335
2685
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
255
3162
0.77
3.64
1.8
1.7
mmol/l
1.4
1.4
0.83
229
2614
(3012516) Albumin [Mass/volume] in Urine
327
3927
0.79
3.61
3.2
3.2
mg/l
1176.6
167.3
1.54
215
2498
(40767503) Oxygen content in Capillary blood by calculation
44
241
1.85
3.59
3.2
2.4
%
15.3
16.4
0.91
25
125
(3028271) Lactate [Moles/volume] in Capillary blood
35
179
1.98
3.50
2.1
1.9
mmol/l
1.6
1.7
0.87
35
173
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
6
10.03
3.50
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
6
10.03
3.50
1.5
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
6
10.03
3.50
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
6
10.03
3.50
1.5
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
106
2.28
3.46
1.1
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
53
312
1.72
3.43
1.5
1.2
u/ml
46.0
51.6
—
8
17
(3032057) Clostridioides difficile [Presence] in Stool
10
27
3.72
3.35
2.0
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
78
510
1.56
3.35
10.0
4.4
%
0.8
0.9
1.19
70
481
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1062
11243
0.81
3.35
4.3
4.7
mmol/l
1.4
1.4
7.36
944
10221
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
40
219
1.85
3.29
1.2
1.2
u/l
38.6
22.4
0.92
33
190
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1073
11341
0.81
3.29
4.4
4.8
mmol/l
4.4
4.5
1.95
958
10380
(3045414) Leukocytes [Presence] in Urine
75
489
1.56
3.27
1.9
1.9
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
19
4.76
3.24
1.7
1.6
—
—
—
0
0
(3036603) Volume of Urine
16
60
2.68
3.23
1.5
1.4
ml
1388.8
1962.8
—
5
16
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
38
3.18
3.21
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
33
3.35
3.19
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
89
607
1.50
3.17
1.3
1.2
u/ml
99.3
250.9
2.20
81
554
(3009508) Creatinine [Moles/volume] in Urine
343
4043
0.80
3.15
3.0
3.2
mmol/l
6.9
7.4
1.69
291
3383
(3008295) Osmolality of Serum or Plasma
24
111
2.18
3.13
1.4
1.4
mosm/kgh2o
272.8
276.9
0.40
16
80
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1128
10659
1.24
3.12
32.1
12.5
ml/min/173m2
75.4
76.0
0.39
1036
8524
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
71
463
1.56
3.11
2.0
2.3
ug/l
626.5
514.2
0.10
65
432
(3003327) Ova and parasites identified in Stool by Light microscopy
49
291
1.71
3.10
1.8
1.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
50
2.82
3.09
2.5
2.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
16
5.02
3.05
1.1
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
16
5.02
3.05
1.9
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
255
1.75
3.03
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
49
294
1.69
2.99
1.5
1.2
u/ml
3.3
3.2
—
8
27
(3045462) Protein/Creatinine [Ratio] in Urine
5
5
10.03
2.98
1.4
7.0
g/mol
9.6
8.6
—
5
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
52
2.71
2.89
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
64
2.52
2.87
1.7
2.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
43
252
1.73
2.87
1.3
1.3
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
13
5.40
2.87
12.9
1.1
—
44.4
—
0
5
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
9
6.69
2.87
1.5
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
9
6.69
2.87
4.0
4.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
49
298
1.67
2.86
1.5
1.2
u/ml
1.6
5.7
—
10
48
(1761868) Lipid panel - Serum or Plasma
300
3553
0.81
2.84
2.8
3.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
31
3.24
2.77
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
286
1.66
2.75
1.4
1.4
ug/g
241.1
303.7
1.36
28
171
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
60
2.52
2.70
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
22
105
2.11
2.69
6.0
3.7
—
—
—
0
0
(3044889) 12 lead EKG panel
885
8232
1.18
2.62
5.1
4.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
55
2.56
2.62
1.5
1.4
u/l
10.8
9.1
—
9
24
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
15
4.68
2.60
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
7
7.16
2.55
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
41
248
1.67
2.48
1.8
2.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
204
1.73
2.42
1.1
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
648
5903
1.17
2.40
2.9
2.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
146
1.86
2.38
2.3
2.7
mg/l
24.1
22.2
—
7
32
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
153
1205
1.30
2.38
3.4
3.2
ng/l
328.7
235.5
1.20
142
1113
(3017446) Testosterone [Moles/volume] in Serum or Plasma
93
679
1.39
2.38
2.2
2.2
nmol/l
12.3
14.8
1.99
79
592
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
58
2.43
2.37
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
58
2.43
2.37
1.1
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
35
2.87
2.30
1.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
55
365
1.53
2.30
2.0
2.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
13
4.63
2.27
1.5
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
56
375
1.51
2.25
4.9
3.9
mmol/l
3.9
3.9
0.27
49
350
(3009542) Hematocrit [Volume Fraction] of Blood
1047
9938
1.18
2.23
33.3
15.1
%
37.0
39.4
10.13
701
6436
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
36
2.79
2.20
1.2
1.1
miu/ml
1302.1
1644.4
—
10
36
(3041096) Erythrocytes [Presence] in Urine by Automated
333
2886
1.20
2.19
4.5
3.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
94
2.03
2.16
1.3
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
14
4.30
2.15
1.5
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
25
3.21
2.09
3.6
3.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
69
2.19
2.05
2.6
2.4
—
—
—
0
0
(4024509)
21
111
1.90
2.01
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
47
692
0.67
2.00
1.6
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
273
1.55
1.96
2.5
2.1
g/l
125.4
132.5
1.07
32
203
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
164
1.72
1.95
2.9
2.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
39
2.57
1.92
3.1
2.3
—
—
—
0
0
(3020891) Body temperature
70
508
1.40
1.90
6.6
4.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
467
1.41
1.87
1.6
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
15
72
2.09
1.86
1.7
2.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.0
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
108
1.86
1.82
2.8
2.3
u/field
1.5
2.1
—
10
39
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
25
145
1.74
1.82
1.1
1.1
—
12.1
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
474
0.63
1.80
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
645
1.34
1.77
3.9
3.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
32
202
1.60
1.72
1.5
1.4
mmol/l
57.1
65.3
0.63
27
161
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
13
3.85
1.71
3.6
3.2
u/field
0.2
0.4
—
5
13
(3002523) Influenza virus A Ag [Presence] in Specimen
18
96
1.89
1.71
1.3
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
68
2.07
1.70
3.3
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
75
2.01
1.70
1.7
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
47
327
1.45
1.64
3.9
4.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
44
628
0.69
1.64
1.3
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
49
2.25
1.63
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
302
0.56
1.63
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
448
0.64
1.60
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
32
2.51
1.59
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
26
2.70
1.58
3.9
2.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
26
2.70
1.58
2.0
1.8
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
40
272
1.48
1.57
16.1
6.1
mmol/l
106.5
105.4
0.64
32
244
(3039000) Anion gap in Blood
40
272
1.48
1.57
16.1
6.1
mmol/l
9.9
11.2
1.64
32
244
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
78
1.93
1.54
1.7
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
64
2.04
1.54
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1048
10874
0.88
1.50
4.0
4.2
mmol/l
1.3
1.3
1.10
934
9789
(3002619) Bacteria identified in Specimen by Culture
6
22
2.73
1.43
1.2
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
22
133
1.66
1.43
1.1
1.0
g/l
1.6
1.5
0.18
22
114
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
40
2.26
1.40
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
470
4321
1.13
1.37
5.1
3.9
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
47
2.14
1.33
1.4
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
61
1.98
1.33
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
61
1.98
1.33
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
208
1811
1.17
1.32
29.5
28.4
inr
1.5
1.4
0.42
26
257
(3044007) Cell count panel - Peritoneal fluid
6
24
2.51
1.30
2.3
3.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
341
3755
0.88
1.28
3.8
3.8
%
21.3
24.1
3.11
162
1822
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
9
44
2.05
1.27
1.3
1.2
—
14.6
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
51
384
1.34
1.19
13.6
5.6
mmol/l
1.2
1.3
0.46
40
341
(3013139) Helicobacter pylori Ag [Presence] in Stool
91
741
1.24
1.18
1.2
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
57
1.94
1.17
1.5
1.3
nmol/l
138.2
147.8
0.45
11
57
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
144
1230
1.19
1.16
2.3
2.5
ug/l
11.5
7.6
0.50
125
1070
(3003129) Base excess in Capillary blood by calculation
8
39
2.06
1.15
3.3
1.7
mmol/l
3.8
0.8
—
8
39
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.2
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
13
72
1.81
1.15
3.5
2.4
ph
7.4
7.4
—
7
26
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
895
8586
1.11
1.13
4.2
3.8
pmol/l
15.1
15.0
0.61
806
7689
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
304
2754
1.13
1.12
1.7
1.7
pmol/l
438.1
33110942.7
2.60
257
2244
(40768446) Kidney Pathology biopsy report
7
31
2.26
1.10
1.4
1.7
—
—
—
0
0
(1002224) Polysomnography panel
25
363
0.68
1.09
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
32
2.19
1.08
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
7
34
2.06
1.03
2.6
2.8
e6/l
576.9
405.3
—
7
28
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
75
610
1.24
1.01
1.1
1.2
iu/ml
63.7
139.9
1.72
16
246
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
48
1.88
1.00
1.4
1.5
ug/l
9.9
9.3
—
9
41
(3000285) Sodium [Moles/volume] in Blood
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
210
0.62
0.95
1.7
1.7
—
—
—
0
0
(4306422)
19
125
1.53
0.94
1.3
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
296
0.71
0.83
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
93
794
1.18
0.81
3.7
3.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
212
0.66
0.80
1.4
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.5
—
137.2
—
0
24
(3051387) C reactive protein [Mass/volume] in Capillary blood
37
286
1.30
0.79
3.8
3.4
mg/l
26.8
27.1
0.02
30
193
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
77
649
1.20
0.78
2.4
2.4
—
—
—
0
0
(4034850)
32
417
0.76
0.78
15.2
11.0
—
—
—
0
0
(4268621)
14
90
1.56
0.78
2.0
2.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1231
12090
1.10
0.75
22.5
9.2
u/l
26.5
25.6
0.52
1217
11531
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
160
1780
0.89
0.74
1.2
1.2
u/ml
13.1
12.8
0.02
56
663
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
622
0.81
0.73
1.6
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
35
272
1.29
0.73
2.2
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
10
60
1.67
0.72
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
1166
0.87
0.71
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
134
1.42
0.71
1.3
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
27
1.85
0.68
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1221
12002
1.09
0.68
37.3
16.4
mmol/l
139.3
139.8
7.56
1212
11647
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
127
1.42
0.68
1.3
1.2
u/ml
2.9
6.2
—
8
61
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
31
240
1.30
0.67
1.1
1.2
—
483.3
—
0
6
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
111
1.45
0.66
2.0
1.5
%
39.5
24.0
0.66
11
73
(3016038) Potassium [Moles/volume] in Urine
12
78
1.54
0.65
1.3
1.2
mmol/l
31.5
34.5
0.23
12
68
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
137
1.39
0.64
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1115
11365
0.93
0.64
5.0
4.9
mmol/l
6.0
6.1
0.97
1008
10218
(3044927) Protein electrophoresis panel - Urine
21
155
1.36
0.63
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
12
79
1.52
0.62
1.7
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
104
0.58
0.62
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
209
0.71
0.59
1.3
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1222
12035
1.08
0.58
38.0
16.5
mmol/l
4.0
4.0
0.14
1209
11660
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
47
561
0.83
0.58
1.6
1.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
73
1.51
0.56
1.0
1.9
umol/l
4.3
5.0
—
5
41
(40761535) Cells panel - Urine sediment
117
1052
1.12
0.55
4.2
3.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
151
1.33
0.54
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
125
1.36
0.53
1.1
1.1
—
—
—
0
0
(4015189)
6
39
1.54
0.53
1.2
2.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
135
1.34
0.51
1.3
1.2
u/ml
1.2
2.2
—
5
45
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
46
1.52
0.48
1.1
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
76
1.45
0.48
2.3
2.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1240
12549
0.93
0.47
50.3
19.9
e9/l
6.9
6.8
0.52
1216
12076
(3000963) Hemoglobin [Mass/volume] in Blood
1240
12548
0.93
0.47
50.7
20.0
g/l
126.0
135.8
75.13
1231
12278
(3026361) Erythrocytes [#/volume] in Blood
1240
12547
0.93
0.46
50.3
19.9
e12/l
4.2
4.5
53.91
1215
12067
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
177
1644
1.09
0.46
12.1
6.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
1240
12546
0.93
0.46
50.1
19.8
pg
30.5
30.5
0.04
1235
12278
(3024731) MCV [Entitic volume]
1240
12545
0.93
0.46
50.2
19.8
fl
91.9
91.5
2.39
1235
12277
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
164
0.73
0.45
1.4
1.3
nmol/l
0.6
0.7
0.68
12
154
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
50
1.40
0.45
1.0
1.1
—
16.5
—
0
10
(3007461) Platelets [#/volume] in Blood
1240
12543
0.93
0.45
50.4
19.9
e9/l
221.3
243.8
24.34
1222
12115
(3020961) Endomysium IgA Ab [Titer] in Serum
49
423
1.16
0.44
1.0
1.1
—
237.8
—
0
11
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
31
1.61
0.43
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
31
1.61
0.43
1.2
1.2
—
—
—
0
0
(4010399)
96
870
1.11
0.43
1.4
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
12
162
0.74
0.42
1.4
1.3
—
0.5
—
0
15
(3029075) Extractable nuclear Ab panel - Serum
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
36
304
1.19
0.42
2.4
3.3
nmol/l
1.1
0.8
0.63
25
231
(3048689) Calprotectin [Mass/mass] in Stool
126
1160
1.09
0.41
2.1
2.2
ug/g
159.8
155.9
0.04
104
900
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.3
—
6.4
—
0
8
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
59
1.36
0.41
1.3
1.3
u/l
174.5
417.0
—
8
53
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
79
1.40
0.40
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
79
1.40
0.40
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
79
1.40
0.40
1.3
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
149
0.74
0.40
1.5
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
104
0.67
0.39
1.4
1.1
—
67.7
—
0
12
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
80
1.38
0.38
1.0
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
114
0.70
0.37
1.5
1.2
nmol/l
2.0
1.5
—
8
99
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
22
267
0.82
0.36
1.2
1.1
—
9.7
—
0
21
(36660697) Celiac disease serology panel - Serum
87
794
1.10
0.36
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
73
1.37
0.34
2.8
1.5
g/l
0.9
1.0
—
10
73
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
254
0.82
0.34
1.3
1.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
921
9358
0.96
0.33
43.4
18.0
g/l
330.5
332.3
7.18
916
9267
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
86
0.70
0.33
1.8
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
86
0.70
0.33
1.8
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
86
0.70
0.33
1.8
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
86
0.70
0.33
1.8
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
88
0.68
0.33
1.7
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
47
1.28
0.32
1.0
1.8
ug/l
13.3
192.5
—
6
41
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
230
2193
1.06
0.32
1.3
1.2
u/ml
1.0
1.8
1.42
48
567
(3021387) Prolactin [Units/volume] in Serum or Plasma
26
220
1.19
0.32
1.7
1.7
mu/l
337.3
287.8
0.41
26
195
(4094501)
37
323
1.15
0.31
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
208
0.82
0.31
1.4
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
31
358
0.86
0.31
2.4
2.2
ug/min
118.9
103.4
0.13
17
218
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
55
1.27
0.30
1.1
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
55
1.27
0.30
2.1
2.1
umol/l
46.7
53.6
—
7
41
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
140
0.78
0.28
1.2
1.3
nmol/l
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
10
76
1.32
0.28
1.2
1.6
umol/l
15.0
13.6
—
10
68
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
85
1.30
0.28
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
168
1.19
0.27
1.7
1.5
—
—
—
0
0
(4211845)
8
66
1.21
0.26
2.5
3.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
182
0.82
0.26
1.1
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
87
1.27
0.24
1.6
2.1
%
12.5
10.7
0.61
11
87
(3027944) Amphetamines [Presence] in Urine
16
190
0.84
0.23
1.1
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
38
1.32
0.23
5.4
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
38
1.32
0.23
5.4
2.9
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
92
0.76
0.22
1.4
1.1
—
5.4
—
0
5
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
163
1561
1.05
0.22
4.6
4.9
%
30.7
33.1
2.18
109
1015
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
10
0.00
0.21
0.0
15.2
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
346
0.89
0.21
1.8
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
190
1828
1.05
0.21
1.2
1.3
iu/ml
59.9
39.5
0.47
60
574
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
155
0.84
0.20
2.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
28
252
1.11
0.18
1.5
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
60
1.17
0.17
2.7
4.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
351
0.91
0.17
1.6
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
152
0.85
0.17
1.2
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
70
1.14
0.16
1.1
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
41
381
1.08
0.15
1.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
192
0.88
0.14
1.1
1.9
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
83
1.08
0.14
1.1
1.1
—
163.6
—
0
14
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
2587
0.97
0.13
2.7
2.7
ug/l
0.7
0.8
0.60
164
1776
(3000764) Benzodiazepines [Presence] in Urine
17
190
0.89
0.13
1.1
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
117
1207
0.97
0.11
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
592
1.05
0.11
1.3
1.3
—
—
—
0
0
(4146454)
13
146
0.89
0.10
3.7
2.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
30
320
0.94
0.09
2.1
1.6
e6/l
11355.9
12585.8
0.09
25
238
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
61
0.82
0.08
1.2
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1173
11690
1.02
0.08
28.4
13.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
88
1.02
0.07
1.0
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
192
0.94
0.05
1.1
1.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
130
0.92
0.04
1.7
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
140
0.93
0.04
1.2
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
262
2639
0.99
0.03
5.0
4.0
kg/l
1.0
1.0
0.53
48
403
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
463
4651
0.99
0.03
4.3
3.9
ug/l
3.8
2.1
0.75
401
4139
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
109
1076
1.01
0.03
2.0
1.7
%
1.4
1.5
1.30
88
916
(3000492) Spirometry study
96
947
1.01
0.03
1.7
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
12
126
0.95
0.00
1.1
1.3
mmol/l
9.6
8.0
—
7
87
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1047
10463
1.00
0.00
5.1
4.6
mu/l
2.1
2.1
0.01
955
9405
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
156
1.03
0.00
1.9
1.5
%
44.8
66.1
—
9
103
(3021788) Differential panel - Synovial fluid
23
232
0.99
0.00
1.7
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
15
151
0.99
0.00
1.8
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
25
249
1.00
0.00
2.4
1.5
nmol/l
1.0
0.8
0.59
17
201
(3011288) Drugs identified in Urine by Screen method
13
127
1.02
0.00
1.2
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
193
0.98
0.00
2.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
350.4
—
0
9
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
66
0.91
0.00
2.2
2.5
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.7
—
0
5
(3032773) Endomysium IgG Ab [Titer] in Serum
8
85
0.94
0.00
1.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
25.8
—
0
9
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
5.3
—
0
9
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.4
—
0
7
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
78
0.90
0.00
1.4
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.7
—
0
5
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
11.7
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
-0.00
0.0
3.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: CD2_NONHODGKIN_NAS_EXALLC – Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).